Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2007
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN100351257C Method for producing pyridoxine or an acid addition salt thereof
11/28/2007CN100351256C Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
11/27/2007US7301019 Method for the preparation of maytansinoid esters
11/27/2007US7300942 For therapy of a fungal infection
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2253613C Therapeutic treatment for vegf related occular diseases
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2006129158A3 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
11/22/2007US20070270585 Cytotoxic agents comprising new maytansinoids
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270433 Thiazolo-pyrimidine/pyridine urea derivatives
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070269447 Cytotoxic agents comprising new maytansinoids
11/22/2007DE202004021399U1 Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen Salt of a sulfonic acid with clopidogrel and its use for the preparation of pharmaceutical formulations
11/21/2007EP1856135A1 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
11/21/2007EP1856131A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
11/21/2007EP1856130A1 Cci-779 polymorph and use thereof
11/21/2007EP1856129A1 39-desmethoxy derivatives of rapamycin
11/21/2007EP1856058A2 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
11/20/2007US7297703 Macrolides
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007WO2007109080A3 Deuterated hepatitis c protease inhibitors
11/15/2007WO2007090579A3 Substituted quinolones iii
11/15/2007WO2007077186A8 Pdf inhibitors
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007US20070265283 Xanthine Oxidase Inhibitor
11/15/2007US20070265249 Fused Bicyclic Aromatic Compounds that are Useful in Treating Sexual Dysfunction
11/15/2007US20070264266 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents
11/15/2007DE202004021381U1 Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen Salt of a sulfonic acid with clopidogrel and its use for the preparation of pharmaceutical formulations
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/14/2007EP1853612A1 Purification of rapamycin
11/14/2007EP1853611A1 Recovery of cci-779 from mother liquors
11/14/2007EP1853597A1 Benzoxazole carboxamides for treating cinv and ibs-d
11/14/2007EP1664058B1 Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
11/14/2007EP1558622B1 Method of purifying macrolides
11/14/2007EP0990654B1 Substituted cyclobutylamine derivatives
11/14/2007CN101072781A Macrocyclic quinazoline derivatives and their use as mtki
11/14/2007CN101072779A 2,4 (4,6) pyrimidine derivatives
11/13/2007US7294715 E.g., 2,9-Diisopropyloxy-1,10-dimethoxy-7-oxoaporphine and 1-methoxy-2-hydroxy-9,10-methylenedioxyaporphine; are used to treat ischemic and metabolic diseases
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125320A1 Pharmaceutical compounds
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007US20070260056 Process for Preparing Bicyclic Pyrazolyl
11/08/2007US20070259912 Polymorphic forms of a GABAA agonist
11/08/2007US20070259907 Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines
11/08/2007US20070259864 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
11/08/2007US20070259846 Dihydrothienopyrimidines; gastrointestinal disorders; cancer
11/08/2007US20070258887 antemortem method of diagnosing Alzheimer's disease and quantitating extent or progression of amyloid deposits by in vivo imaging of brain
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007EP1852437A2 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
11/07/2007EP1850844A2 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
11/07/2007EP1523486B1 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
11/07/2007CN101068820A Non-hygroscopic and powdery amorphous pimecrolimus
11/07/2007CN101068819A Processes for producing crystalline macrolides
11/07/2007CN101068818A Methods of preparing pimecrolimus
11/07/2007CN101068795A Heterocyclical chromophore architectures with novel electronic acceptor systems
11/07/2007CN100347184C Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses
11/06/2007US7291733 pyrido[3',2':4,5]thieno[3,2-d]-pyrimidines (or triazines or pyridines); inhibitors of the kinase activity of the I kappa B kinase (IKK) complex; autoimmune diseases, inflammatory diseases and cancer; lupus, rheumatoid arthritis, breast canser
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291618 (3,3-Difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-(pyrimidin-2-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone, usedin treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124337A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1
11/01/2007WO2007123892A2 Raf inhibitors and their uses
11/01/2007WO2007122258A1 Tryclic nitrogen containing compounds and their use as antibacterials
11/01/2007WO2006103399A8 Hiv integrase inhibitors
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254876 Glucuronate salt of a piperazine compound
11/01/2007US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007CA2650009A1 Il-8 receptor antagonists
10/2007
10/31/2007EP1848722A1 Amorphous taclolimus solid dispersion having an enhanced solubility and pharmaceutical composition comprising same
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848506A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines
10/31/2007EP1848420A2 Polymorphic forms of a gabaa agonist
10/31/2007EP1537122B9 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
10/31/2007CN101065385A Rifamycin derivatives for treating microbial infections
10/30/2007US7288655 α v integrin receptor antagonists
10/30/2007US7288647 Recovery of CCI-779 from mother liquors
10/30/2007US7288561 Such as N,N-dimethyl-3-(phenylsulfonyl)-6,7,8,9-tetrahydro-3H-benzo[e]indol-8-amine; for treatment of central nervous system disorders related to or affected by serotonin receptor antagonists such as neurodegenerative disorders, attention deficit disorder, obsessive compulsive disorder, and drug abuse
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/25/2007WO2007121299A2 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
10/25/2007WO2007120594A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007US20070249636 Selected Fused Heterocyclics and Uses Thereof
10/25/2007US20070249614 Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Uses Thereof
10/25/2007US20070248624 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
10/25/2007CA2647141A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/24/2007EP1846416A2 Antibacterial agents
10/23/2007US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 220